Tag: Kaluga Pharmcluster

Cluster «Pharmaceutical, biotechnology and biomedicine» Kaluga Region was formed in 2011 and in March 2012 was legally registered as a non-profit partnership «Kaluga pharmaceutical cluster».
Industry cluster specialized– conducting preclinical and clinical studies, development, synthesis and implementation into production of pharmaceutical substances and radiopharmaceuticals, manufacturing of finished pharmaceutical products (FPP) and pharmaceutical substances, infusion solutions and parenteral nutrition.

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

Kaluga Pharmaceutical Cluster increases output of medicines by more than 80%

In 2017, the companies of Kaluga Pharmaceutical Cluster increased their output of medicinal products by more than 80%. This was announced by the Governor of Kaluga region Anatoly Artamonov.

Pharmaceutical industry grew by 80% in Kaluga region

The Governor of Kaluga region Anatoly Artamonov held a press conference on the results of outgoing year

Kaluga Pharmaceutical Cluster received silver certificate of Cluster Excellence

kaluga pharmaceutical cluster
Kaluga Pharmaceutical Cluster passed the procedure of the on-site audit conducted by the experts of the European Secretariat for Cluster Analysis

Kaluga Pharmaceutical Cluster will become an entry point for German companies

An agreement on cooperation between the Association of Kaluga Pharmaceutical Cluster and Steinbeis Global Institute Tübingen was signed on October 16

Park of Active Molecules and Montpellier Agglomeration will collaborate

The memorandums on scientific partnership between the organizations of Montpellier Agglomeration and Kaluga region were signed in the city of Montpellier

AstraZeneca starts manufacturing drug targeting cancer cells in Kaluga

astrazeneca kaluga
AstraZeneca, an international biopharmaceutical company, launched a new high-tech manufacturing process at its plant in Vorsino industrial park of Kaluga region

Merck and Kaluga pharmcluster signed a partnership agreement

The collaboration with Merck, a science and technology company, assumes active cooperation for the development life science technologies in the Kaluga region. The parties defined the priority areas fo...

Two pharmaceutical plants will be opened in Kaluga region by the end of 2017

Speaking at the PharmEvolution, the 3rd international forum on the development of pharmaceutical industry in Russia, Anatoly Artamonov, the Governor of the Kaluga region, said, “In 2016, the productio...

Kaluga pharmaceutical cluster acquires new partner

A strategic partnership agreement between Kaluga pharmaceutical cluster and Pharmcontract Group, a leading Russian chemical and pharmaceutical holding company, was officially signed on April 4 at Phar...